These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 14751573)

  • 1. A selective EP4 receptor antagonist abrogates the stimulation of osteoblast recruitment from bone marrow stromal cells by prostaglandin E2 in vivo and in vitro.
    Shamir D; Keila S; Weinreb M
    Bone; 2004 Jan; 34(1):157-62. PubMed ID: 14751573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin E2 (PGE2) increases the number of rat bone marrow osteogenic stromal cells (BMSC) via binding the EP4 receptor, activating sphingosine kinase and inhibiting caspase activity.
    Weinreb M; Shamir D; Machwate M; Rodan GA; Harada S; Keila S
    Prostaglandins Leukot Essent Fatty Acids; 2006 Aug; 75(2):81-90. PubMed ID: 16890416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anabolic effect of PGE2 in rat bone marrow cultures is mediated via the EP4 receptor subtype.
    Weinreb M; Grosskopf A; Shir N
    Am J Physiol; 1999 Feb; 276(2):E376-83. PubMed ID: 9950799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KMN-159, a novel EP
    Owen TA; Patel C; Wei S; Ho CS; Birmingham K; Sanchez S; Chung N; Cahill A; O'Malley JP; Barrett SD; Morano MI
    Gene; 2020 Jul; 748():144668. PubMed ID: 32334025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of deletion of the prostaglandin EP2 receptor on the anabolic response to prostaglandin E2 and a selective EP2 receptor agonist.
    Choudhary S; Alander C; Zhan P; Gao Q; Pilbeam C; Raisz L
    Prostaglandins Other Lipid Mediat; 2008 Jun; 86(1-4):35-40. PubMed ID: 18406186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic prostaglandin E2 increases cancellous bone formation and mass in aging rats and stimulates their bone marrow osteogenic capacity in vivo and in vitro.
    Keila S; Kelner A; Weinreb M
    J Endocrinol; 2001 Jan; 168(1):131-9. PubMed ID: 11139777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic administration of an anabolic dose of PGE2 in young rats increases the osteogenic capacity of bone marrow.
    Weinreb M; Suponitzky I; Keila S
    Bone; 1997 Jun; 20(6):521-6. PubMed ID: 9177865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of global or targeted deletion of the EP4 receptor on the response of osteoblasts to prostaglandin in vitro and on bone histomorphometry in aged mice.
    Gao Q; Zhan P; Alander CB; Kream BE; Hao C; Breyer MD; Pilbeam CC; Raisz LG
    Bone; 2009 Jul; 45(1):98-103. PubMed ID: 19344793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of cyclo-oxigenase-2 activity does not abolish the anabolic effect of prostaglandin E2 in vivo or in vitro.
    Weinreb M; Kelner A; Keila S
    J Endocrinol; 2002 Jul; 174(1):127-35. PubMed ID: 12098671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin E2-mediated anabolic effect of a novel inhibitor of phosphodiesterase 4, XT-611, in the in vitro bone marrow culture.
    Miyamoto K; Suzuki H; Yamamoto S; Saitoh Y; Ochiai E; Moritani S; Yokogawa K; Waki Y; Kasugai S; Sawanishi H; Yamagami H
    J Bone Miner Res; 2003 Aug; 18(8):1471-7. PubMed ID: 12929936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin E2 stimulates the formation of mineralized bone nodules by a cAMP-independent mechanism in the culture of adult rat calvarial osteoblasts.
    Kaneki H; Takasugi I; Fujieda M; Kiriu M; Mizuochi S; Ide H
    J Cell Biochem; 1999 Apr; 73(1):36-48. PubMed ID: 10088722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of selective prostaglandin EP4 receptor antagonist on osteoclast formation and bone resorption in vitro.
    Tomita M; Li X; Okada Y; Woodiel FN; Young RN; Pilbeam CC; Raisz LG
    Bone; 2002 Jan; 30(1):159-63. PubMed ID: 11792579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of prostaglandin E2 on gene expression in primary osteoblastic cells from prostaglandin receptor knockout mice.
    Li X; Pilbeam CC; Pan L; Breyer RM; Raisz LG
    Bone; 2002 Apr; 30(4):567-73. PubMed ID: 11934647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of PKA and phosphorylation of sodium-dependent vitamin C transporter 2 by prostaglandin E2 promote osteoblast-like differentiation in MC3T3-E1 cells.
    Wu X; Zeng LH; Taniguchi T; Xie QM
    Cell Death Differ; 2007 Oct; 14(10):1792-801. PubMed ID: 17585336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin E2 acts via bone marrow macrophages to block PTH-stimulated osteoblast differentiation in vitro.
    Choudhary S; Blackwell K; Voznesensky O; Deb Roy A; Pilbeam C
    Bone; 2013 Sep; 56(1):31-41. PubMed ID: 23639875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation.
    Yoshida K; Oida H; Kobayashi T; Maruyama T; Tanaka M; Katayama T; Yamaguchi K; Segi E; Tsuboyama T; Matsushita M; Ito K; Ito Y; Sugimoto Y; Ushikubi F; Ohuchida S; Kondo K; Nakamura T; Narumiya S
    Proc Natl Acad Sci U S A; 2002 Apr; 99(7):4580-5. PubMed ID: 11917107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of basic fibroblast growth factor and a prostaglandin E2 receptor subtype 4 agonist on osteoblastogenesis and adipogenesis in aged ovariectomized rats.
    Aguirre JI; Leal ME; Rivera MF; Vanegas SM; Jorgensen M; Wronski TJ
    J Bone Miner Res; 2007 Jun; 22(6):877-88. PubMed ID: 17352655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of growth and differentiation of osteoprogenitors in mouse bone marrow stromal cell cultures by increased donor age and glucocorticoid treatment.
    Chen TL
    Bone; 2004 Jul; 35(1):83-95. PubMed ID: 15207744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow cells are targets for the anabolic actions of prostaglandin E2 on bone: induction of a transition from nonadherent to adherent osteoblast precursors.
    Scutt A; Bertram P
    J Bone Miner Res; 1995 Mar; 10(3):474-87. PubMed ID: 7785470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Important role of EP4, a subtype of prostaglandin (PG) E receptor, in osteoclast-like cell formation from mouse bone marrow cells induced by PGE2.
    Ono K; Akatsu T; Murakami T; Nishikawa M; Yamamoto M; Kugai N; Motoyoshi K; Nagata N
    J Endocrinol; 1998 Sep; 158(3):R1-5. PubMed ID: 9846175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.